| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.44 | 1e-10 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.39 | 1e-08 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.18 | 6e-08 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.29 | 3e-07 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0004 |